Asher Marks, MD

• David Frumberg
• Farzana Pashankar
• Henry S. Park
• Juan Vasquez
• Mariam Aboian
• Pei Hui
• Ranjit S. Bindra
• Thomas Murray
• Zeynep Erson Omay

Brain Neoplasms; Hematology; Medical Oncology; Neoplasms; Pediatrics; Virtual Reality; Digital Divide

• Disinfection of Virtual Reality Devices in Health Care Settings: In Vitro Assessment and Survey StudyRoberts S, Havill N, Flores RM, Hendrix C, Williams MJ, Feinn RS, Choi SJ, Martinello RA, Marks AM, Murray TS. Disinfection of Virtual Reality Devices in Health Care Settings: In Vitro Assessment and Survey Study Journal Of Medical Internet Research 2022, 24: e42332. PMID: 36269222, PMCID: PMC9756115, DOI: 10.2196/42332.
• NFB-05. A family-centered neurocutaneous syndrome clinic in the age of targeted therapiesMarks A, Antaya R, Balsamo L, Cardinale K, Cheron R, Frumberg D, Gentile V, Habib L, Puthenpura V, Zhang H. NFB-05. A family-centered neurocutaneous syndrome clinic in the age of targeted therapies Neuro-Oncology 2022, 24: i129-i129. PMCID: PMC9165028, DOI: 10.1093/neuonc/noac079.469.
• Radiation Necrosis with Proton Therapy in a Patient with Aarskog-Scott Syndrome and MedulloblastomaPuthenpura V, DeNunzio NJ, Zeng X, Giantsoudi D, Aboian M, Ebb D, Kahle KT, Yock TI, Marks AM. Radiation Necrosis with Proton Therapy in a Patient with Aarskog-Scott Syndrome and Medulloblastoma International Journal Of Particle Therapy 2021, 8: 58-65. PMID: 35127977, PMCID: PMC8768897, DOI: 10.14338/ijpt-21-00013.1.
• Racial/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumorsPuthenpura V, Canavan ME, Poynter JN, Roth M, Pashankar FD, Jones BA, Marks AM. Racial/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors Pediatric Blood & Cancer 2021, 68: e28970. PMID: 33704901, PMCID: PMC8221084, DOI: 10.1002/pbc.28970.
• Clinical Application of Digital Technologies in Adolescent and Young Adult Oncology Supportive CarePuthenpura V, Marks AM. Clinical Application of Digital Technologies in Adolescent and Young Adult Oncology Supportive Care Journal Of Adolescent And Young Adult Oncology 2020, 10: 127-130. PMID: 33296259, PMCID: PMC8182471, DOI: 10.1089/jayao.2020.0153.
• Loss to follow‐up of minorities, adolescents, and young adults on clinical trials: A report from the Children's Oncology GroupPuthenpura V, Ji L, Xu X, Roth M, Freyer D, Frazier A, Marks A, Pashankar F. Loss to follow‐up of minorities, adolescents, and young adults on clinical trials: A report from the Children's Oncology Group Cancer 2023 PMID: 36813754, DOI: 10.1002/cncr.34701.
• Spectrum of qualitative and quantitative imaging of pilomyxoid, intermediate pilomyxoid and pilocytic astrocytomas in relation to their genetic alterationsFadel SA, von Reppert M, Kazarian E, Omay EZE, Marks A, Linder N, Hoffmann KT, Darbinyan A, Huttner A, Aboian MS. Spectrum of qualitative and quantitative imaging of pilomyxoid, intermediate pilomyxoid and pilocytic astrocytomas in relation to their genetic alterations Neuroradiology 2022, 1-11. PMID: 35984480, DOI: 10.1007/s00234-022-03027-3.
• CLRM-03. BGB-290 AND TEMOZOLOMIDE IN TREATING ISOCITRATE DEHYDROGENASE (IDH)1/2-MUTANT GRADE I-IV GLIOMAS – A NOVEL MODEL OF AYA TRIAL DEVELOPMENT AND DEPLOYMENTMarks A, Bindra R. CLRM-03. BGB-290 AND TEMOZOLOMIDE IN TREATING ISOCITRATE DEHYDROGENASE (IDH)1/2-MUTANT GRADE I-IV GLIOMAS – A NOVEL MODEL OF AYA TRIAL DEVELOPMENT AND DEPLOYMENT Neuro-Oncology Advances 2021, 3: iv1-iv1. PMCID: PMC8453774, DOI: 10.1093/noajnl/vdab112.002.
• Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomasKazarian E, Marks A, Cui J, Darbinyan A, Tong E, Mueller S, Cha S, Aboian MS. Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas Scientific Reports 2021, 11: 14377. PMID: 34257334, PMCID: PMC8277861, DOI: 10.1038/s41598-021-92943-0.
• Dual activating FGFR1 mutations in pediatric pilomyxoid astrocytomaFomchenko EI, Reeves BC, Sullivan W, Marks AM, Huttner A, Kahle KT, Erson‐Omay E. Dual activating FGFR1 mutations in pediatric pilomyxoid astrocytoma Molecular Genetics & Genomic Medicine 2021, 9: e1597. PMID: 33448156, PMCID: PMC8077124, DOI: 10.1002/mgg3.1597.
• Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastomaHong CS, Vasquez JC, Kundishora AJ, Elsamadicy AA, Beckta JM, Sule A, Marks AM, Leelatian N, Huttner A, Bindra RS, DiLuna ML, Kahle KT, Erson-Omay EZ. Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma Npj Genomic Medicine 2020, 5: 23. PMID: 32528726, PMCID: PMC7264170, DOI: 10.1038/s41525-020-0130-7.
• Genomic alterations underlying spinal metastases in pediatric H3K27M-mutant pineal parenchymal tumor of intermediate differentiation: case report.Fomchenko EI, Erson-Omay EZ, Kundishora AJ, Hong CS, Daniel AA, Allocco A, Duy PQ, Darbinyan A, Marks AM, DiLuna ML, Kahle KT, Huttner A. Genomic alterations underlying spinal metastases in pediatric H3K27M-mutant pineal parenchymal tumor of intermediate differentiation: case report. Journal Of Neurosurgery Pediatrics 2019, 25: 1-10. PMID: 31653819, DOI: 10.3171/2019.8.peds18664.
• HGG-01. ACQUISITION OF A HYPERMUTATOR PHENOTYPE UNDERLYING DISTANT SPINAL INTRAMEDULLARY SPREAD IN HISTONE-MUTATED DIFFUSE MIDLINE GLIOMAHong C, Kundishora A, Fomchenko E, Huttner A, Erson-Omay Z, Marks A, Diluna M, Kahle K. HGG-01. ACQUISITION OF A HYPERMUTATOR PHENOTYPE UNDERLYING DISTANT SPINAL INTRAMEDULLARY SPREAD IN HISTONE-MUTATED DIFFUSE MIDLINE GLIOMA Neuro-Oncology 2019, 21: ii86-ii86. PMCID: PMC6477387, DOI: 10.1093/neuonc/noz036.095.
• PDTM-35. GENETIC ALTERATIONS DRIVING SPINAL INTRAMEDULLARY METASTASES OF A HISTONE-MUTATED DIFFUSE MIDLINE PINEAL GLIOMAHong C, Kundishora A, Erson Omay E, Huttner A, Marks A, Diluna M, Kahle K. PDTM-35. GENETIC ALTERATIONS DRIVING SPINAL INTRAMEDULLARY METASTASES OF A HISTONE-MUTATED DIFFUSE MIDLINE PINEAL GLIOMA Neuro-Oncology 2018, 20: vi211-vi211. PMCID: PMC6217703, DOI: 10.1093/neuonc/noy148.875.
• The coexistence of lupus erythematosus panniculitis and subcutaneous panniculitislike T-cell lymphoma in the same patientWu X, Subtil A, Craiglow B, Watsky K, Marks A, Ko C. The coexistence of lupus erythematosus panniculitis and subcutaneous panniculitislike T-cell lymphoma in the same patient JAAD Case Reports 2018, 4: 179-184. PMID: 29892661, PMCID: PMC5993551, DOI: 10.1016/j.jdcr.2017.08.021.
• Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenibMarks AM, Bindra RS, DiLuna ML, Huttner A, Jairam V, Kahle KT, Kieran MW. Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib Pediatric Blood & Cancer 2018, 65: e26969. PMID: 29380516, DOI: 10.1002/pbc.26969.
• PDTM-25. GENETIC SUSCEPTIBILITY AND EVOLUTION OF PEDIATRIC IDH-MUTANT INFILTRATING ASTROCYTOMASBornhorst M, Goecks J, Boue D, Broniscer A, Hwang E, Koschmann C, Marks A, Mody R, Mueller S, Orr B, Packer R, Solomon D, Turner J, Vortmeyer A, Nazarian J, Ho C. PDTM-25. GENETIC SUSCEPTIBILITY AND EVOLUTION OF PEDIATRIC IDH-MUTANT INFILTRATING ASTROCYTOMAS Neuro-Oncology 2017, 19: vi195-vi195. PMCID: PMC5692642, DOI: 10.1093/neuonc/nox168.789.
• Low-Grade Astrocytoma within a Mature Cystic Teratoma in an Adolescent PatientYoder N, Marks A, Hui P, Litkouhi B, Cron J. Low-Grade Astrocytoma within a Mature Cystic Teratoma in an Adolescent Patient Journal Of Pediatric And Adolescent Gynecology 2017, 31: 325-327. PMID: 29107097, DOI: 10.1016/j.jpag.2017.10.005.
• SOX2 immunity and tissue resident memory in children and young adults with gliomaVasquez JC, Huttner A, Zhang L, Marks A, Chan A, Baehring JM, Kahle KT, Dhodapkar KM. SOX2 immunity and tissue resident memory in children and young adults with glioma Journal Of Neuro-Oncology 2017, 134: 41-53. PMID: 28620836, PMCID: PMC7906294, DOI: 10.1007/s11060-017-2515-8.
• SOX2 as a target for immunotherapy of pediatric gliomas.Vasquez J, Huttner A, Zhang L, Marks A, Chan A, Baehring J, Kahle K, Dhodapkar K. SOX2 as a target for immunotherapy of pediatric gliomas. Journal Of Clinical Oncology 2017, 35: e22012-e22012. DOI: 10.1200/jco.2017.35.15_suppl.e22012.
• Low-Grade Astrocytoma Within a Mature Cystic Teratoma in an Adolescent Patient: A Case ReportYoder N, Marks A, Hui P, Litkouhi B, Cron J. Low-Grade Astrocytoma Within a Mature Cystic Teratoma in an Adolescent Patient: A Case Report Journal Of Pediatric And Adolescent Gynecology 2017, 30: 295. DOI: 10.1016/j.jpag.2017.03.059.
• Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young ChildrenKann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Khan AJ, Bindra RS, Marks AM, Roberts KB. Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children JAMA Oncology 2016, 2: 1574-1581. PMID: 27491009, DOI: 10.1001/jamaoncol.2016.2547.
• Adjuvant Radiation Therapy Patterns and Survival Implications for Medulloblastoma in Young ChildrenKann B, Park H, Lester-Coll N, Yeboa D, Benitez V, Bindra R, Khan A, Marks A, Roberts K. Adjuvant Radiation Therapy Patterns and Survival Implications for Medulloblastoma in Young Children International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s230-s231. DOI: 10.1016/j.ijrobp.2016.06.573.
• Primary spinal myxopapillary ependymoma in the pediatric population: a study from the Surveillance, Epidemiology, and End Results (SEER) databaseLucchesi KM, Grant R, Kahle KT, Marks AM, DiLuna ML. Primary spinal myxopapillary ependymoma in the pediatric population: a study from the Surveillance, Epidemiology, and End Results (SEER) database Journal Of Neuro-Oncology 2016, 130: 133-140. PMID: 27423644, DOI: 10.1007/s11060-016-2218-6.
• MB-38ADJUVANT RADIOTHERAPY PATTERNS OF CARE AND SURVIVAL IMPLICATIONS FOR MEDULLOBLASTOMA IN YOUNG CHILDRENKann B, Park H, Lester-Coll N, Yeboa D, Benitez V, Bindra R, Khan A, Marks A, Roberts K. MB-38ADJUVANT RADIOTHERAPY PATTERNS OF CARE AND SURVIVAL IMPLICATIONS FOR MEDULLOBLASTOMA IN YOUNG CHILDREN Neuro-Oncology 2016, 18: iii105.2-iii105. PMCID: PMC4903595, DOI: 10.1093/neuonc/now076.36.
• Craniopharyngioma arising in a Rathke's cleft cyst: case report.Alomari AK, Kelley BJ, Damisah E, Marks A, Hui P, DiLuna M, Vortmeyer A. Craniopharyngioma arising in a Rathke's cleft cyst: case report. Journal Of Neurosurgery Pediatrics 2015, 15: 250-4. PMID: 25555112, DOI: 10.3171/2014.11.peds14370.
• Hemoglobin shady grove: A novel fetal methemoglobin variantMarks A, Luo H, Chui DH, Greenberg J. Hemoglobin shady grove: A novel fetal methemoglobin variant Pediatric Blood & Cancer 2013, 60: e55-e56. PMID: 23460588, DOI: 10.1002/pbc.24503.
• A Review of Secondary Central Nervous System Tumors After Treatment of a Primary Pediatric MalignancyMarks AM, Packer RJ. A Review of Secondary Central Nervous System Tumors After Treatment of a Primary Pediatric Malignancy Seminars In Pediatric Neurology 2012, 19: 43-48. PMID: 22641075, DOI: 10.1016/j.spen.2012.02.015.
• Index of SuspicionManiscalco J, Dryer A, Marks A, Yunghans M. Index of Suspicion Pediatrics In Review 2008, 29: 321-328. DOI: 10.1542/pir.29.9.321.
• Index of SuspicionManiscalco J, Dryer AL, Marks A, Yunghans M, Pierson SB, Sgarlat CM, Sveen AR, Blanch LE. Index of Suspicion Pediatrics In Review 2008, 29: 321-328. PMID: 18765471, DOI: 10.1542/pir.29-9-321.